Identifying neutrophil-associated subtypes in ulcerative colitis and confirming neutrophils promote colitis-associated colorectal cancer
- 1Colorectal & Anal Surgery Department, General Surgery Center, First Hospital of Jilin University, Changchun, Jilin, China
- 2Central Laboratory, First Hospital of Jilin University, Changchun, Jilin, China
- 3Echocardiography Department, First Hospital of Jilin University, Changchun, Jilin, China
- 4Department of Respiratory Medicine, First Affiliated Hospital of Jilin University, Changchun, Jilin, China
A corrigendum on
Identifying neutrophil-associated subtypes in ulcerative colitis and confirming neutrophils promote colitis-associated colorectal cancer
by Zhang C, Zhang J, Zhang Y, Song Z, Bian J, Yi H and Ma Z (2023). Front. Immunol. 14:1095098. doi: 10.3389/fimmu.2023.1095098
In the published article, there was an error. Detailed sample information was missing.
A correction has been made to Materials and methods, Data collection and processing, paragraph 1 This sentence previously stated:
“A total of 803 RNA-seq samples were downloaded from datasets GSE87473, GSE92415, and GSE206285, including untreated 743 UC samples and 60 healthy control samples”
The corrected sentence appears below:
“A total of 803 RNA-seq samples were downloaded from datasets GSE87473, GSE92415, and GSE206285, including untreated 743 UC samples and 60 healthy control samples. It should be noticed that though 364 patients with UC were treated with ustekinumab (data extracted from database GSE206285), RNA extraction and microarray analysis of biopsy samples collected when the data set was uploaded at baseline. Baseline is the period of time in a clinical study when a patient has been screened to for the study but has not yet started medication.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: ulcerative colitis, colitis-associated colorectal cancer, immune cell infiltration, biomarker, neutrophil
Citation: Zhang C, Zhang J, Zhang Y, Song Z, Bian J, Yi H and Ma Z (2024) Corrigendum: Identifying neutrophil-associated subtypes in ulcerative colitis and confirming neutrophils promote colitis-associated colorectal cancer. Front. Immunol. 15:1376797. doi: 10.3389/fimmu.2024.1376797
Received: 26 January 2024; Accepted: 18 March 2024;
Published: 10 April 2024.
Edited and Reviewed by:
Kai Yin, Jiangsu University, ChinaCopyright © 2024 Zhang, Zhang, Zhang, Song, Bian, Yi and Ma. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Huanfa Yi, yihuanfa@jlu.edu.cn; Zhanchuan Ma, mazc15@mails.jlu.edu.cn
†These authors have contributed equally to this work